# Sanofi Genzyme

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/sanofi-genzyme/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company |
| OpenAlex ID | https://openalex.org/F4320333587 |
| Works | 3,851 |

## Funder papers

- [Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment](https://scholariq.org/papers/economic-burden-of-adult-patients-with-moderate-to-severe-atopic-dermatitis/)
- [Insights From Caregivers on the Impact of Pediatric Atopic Dermatitis on Families: “I’m Tired, Overwhelmed, and Feel Like I’m Failing as a Mother”](https://scholariq.org/papers/insights-from-caregivers-on-the-impact-of-pediatric-atopic-dermatitis-on/)
- [Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review](https://scholariq.org/papers/global-incidence-of-iga-nephropathy-by-race-and-ethnicity-a-systematic-review/)
- [Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database](https://scholariq.org/papers/costs-and-treatment-patterns-among-patients-with-atopic-dermatitis-using/)
- [Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria](https://scholariq.org/papers/hemolysis-induced-by-sars-cov-2-mrna-vaccination-in-patients-with-paroxysmal/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.